Burghaus-Zhang, J., Schulz, C., Ramelyte, E., Mangana, J., Özistanbullu, D., Kleemann, J., . . . Hassel, J. C. (2026). Re-exposure of a PD-1 inhibitor after previous immune-related adverse events. Current oncology, 33(4), . https://doi.org/10.3390/curroncol33040180
Cita Chicago Style (17a ed.)Burghaus-Zhang, Jana, Carsten Schulz, Egle Ramelyte, Joanna Mangana, Deniz Özistanbullu, Johannes Kleemann, Alexander Enk, y Jessica C. Hassel. "Re-exposure of a PD-1 Inhibitor After Previous Immune-related Adverse Events." Current Oncology 33, no. 4 (2026). https://doi.org/10.3390/curroncol33040180.
Cita MLA (9a ed.)Burghaus-Zhang, Jana, et al. "Re-exposure of a PD-1 Inhibitor After Previous Immune-related Adverse Events." Current Oncology, vol. 33, no. 4, 2026, https://doi.org/10.3390/curroncol33040180.